ALCOHOL-ASSOCIATED LIVER DISEASE
Clinical trials for ALCOHOL-ASSOCIATED LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALCOHOL-ASSOCIATED LIVER DISEASE trials appear
Sign up with your email to follow new studies for ALCOHOL-ASSOCIATED LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to keep liver transplant patients sober
Disease control Recruiting nowThis study tests whether adding addiction monitoring after a liver transplant can reduce the rate of alcohol relapse. About 720 adults who received a liver transplant due to alcohol-related liver disease will be followed for two years. The goal is to see if this extra support hel…
Matched conditions: ALCOHOL-ASSOCIATED LIVER DISEASE
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
Gut health breakthrough: probiotic may curb alcohol cravings and liver harm
Disease control Recruiting nowThis study tests whether taking a probiotic called Lactobacillus rhamnosus GG (LGG) for 6 months can help people with alcohol use disorder drink less and reduce liver injury. About 60 heavy drinkers with alcohol-related liver disease will receive either LGG or a placebo. The goal…
Matched conditions: ALCOHOL-ASSOCIATED LIVER DISEASE
Phase: PHASE2 • Sponsor: University of Louisville • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Liver clinics to offer alcohol addiction treatment in new study
Knowledge-focused Recruiting nowThis study looks at whether it's possible and acceptable to train liver doctors to provide medication and brief counseling for alcohol use disorder. About 30 healthcare providers who treat liver disease will take part. The goal is to make it easier for patients with both alcohol-…
Matched conditions: ALCOHOL-ASSOCIATED LIVER DISEASE
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC
-
Can a cholesterol drug protect heavy Drinkers' livers?
Knowledge-focused Recruiting nowThis early-stage study tests whether alirocumab, a drug used for high cholesterol, is safe and may reduce liver inflammation in heavy drinkers. About 100 healthy adults who drink 20+ alcoholic beverages per week will receive either the drug or a placebo injection for 8 weeks. Res…
Matched conditions: ALCOHOL-ASSOCIATED LIVER DISEASE
Phase: PHASE1 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC